Genomic Insights into and In Vitro Evaluation of Antimicrobial Combination Therapies for Carbapenem-Resistant Acinetobacter baumannii
Abstract
Share and Cite
Ijaz, S.; Ansari, F.; Nawaz, M.; Ejaz, H.; Anjum, A.A.; Saeed, A.; Ali, T.; Rehman, O.U.; Fatima, E.; Ijaz, T. Genomic Insights into and In Vitro Evaluation of Antimicrobial Combination Therapies for Carbapenem-Resistant Acinetobacter baumannii. Medicina 2024, 60, 1086. https://doi.org/10.3390/medicina60071086
Ijaz S, Ansari F, Nawaz M, Ejaz H, Anjum AA, Saeed A, Ali T, Rehman OU, Fatima E, Ijaz T. Genomic Insights into and In Vitro Evaluation of Antimicrobial Combination Therapies for Carbapenem-Resistant Acinetobacter baumannii. Medicina. 2024; 60(7):1086. https://doi.org/10.3390/medicina60071086
Chicago/Turabian StyleIjaz, Saadia, Farheen Ansari, Muhammad Nawaz, Hasan Ejaz, Aftab Ahmad Anjum, Aqib Saeed, Tehreem Ali, Obaid Ur Rehman, Eeshal Fatima, and Tayyaba Ijaz. 2024. "Genomic Insights into and In Vitro Evaluation of Antimicrobial Combination Therapies for Carbapenem-Resistant Acinetobacter baumannii" Medicina 60, no. 7: 1086. https://doi.org/10.3390/medicina60071086